Annual Secretarial Compliance Report for the quarter and year ended 31 March 2025
HESTERBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Hester Biosciences has submitted its Annual Secretarial Compliance Report for the financial year ended 31 March 2025 to NSE and BSE, as required under Regulation 24A of SEBI LODR Regulations. The report, certified by Practicing Company Secretary Mr. Tapan Shah (dated 9 May 2025), confirms that the company has generally complied with all material provisions of applicable SEBI regulations and circulars. All 12 checklist items—including secretarial standards, policy adoption, website disclosures, director qualifications, related party transactions, insider trading, and event disclosures—were marked compliant (Yes or Not Applicable). No prior observations were carried forward, no additional non-compliances were observed, and no actions were taken against the company, its promoters, or directors by SEBI or stock exchanges during the review period.
This is a routine annual regulatory filing with no material impact on the stock price or shareholders. The clean compliance status confirms sound corporate governance practices and no regulatory penalties or warnings against the company.